vspВопросы современной педиатрииCurrent Pediatrics1682-55271682-5535Издательство «ПедиатрЪ»10.15690/vsp.v14i1.1266vsp-92Research ArticleНЕПРЕРЫВНОЕ ПРОФЕССИОНАЛЬНОЕ ОБРАЗОВАНИЕPROFESSIONAL DEVELOPMENTЮВЕНИЛЬНЫЙ ИДИОПАТИЧЕСКИЙ АРТРИТ: КЛИНИЧЕСКАЯ КАРТИНА, ДИАГНОСТИКА, ЛЕЧЕНИЕJUVENILE IDIOPATHIC ARTHRITIS: CLINICAL PICTURE, DIAGNOSIS, TREATMENTАлексееваЕ. И.AlexeevaE. I.

доктор медицинских наук, профессор, заведующая ревматологическим отделением НЦЗД, декан педиатрического факультета Первого МГМУ им. И.М. Сеченова

alekatya@ya.ruНаучный центр здоровья детей, Москва, Российская Федерация Первый Московский государственный медицинский университет им. И.М. Сеченова, Российская ФедерацияРоссияScientific Centre of Children’s Health, Moscow, Russian Federation Sechenov First Moscow State Medical University, Russian FederationRussian Federation201514022015141Вопросы современной педиатрии7894Copyright © Алексеева Е.И., 20152015Алексеева Е.И.Alexeeva E.I.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://vsp.spr-journal.ru/jour/article/view/92

В лекции представлены современные данные о механизмах развития, клинических признаках, диагностике, прогнозе и лечении ювенильного идиопатического артрита.

 

The lecture presents current data on the development mechanisms, clinical features, diagnosis, prognosis and treatment of juvenile idiopathic arthritis.

 

ювенильный идиопатический артритдетииммунная аутоагрессияметотрексатгенно-инженерные биологические препаратыjuvenile idiopathic arthritischildrenimmune autoaggressionmethotrexategenetically engineered biologic drugsReferencesBaranov А.А., Alexeeva E.I. Yuvenil'nyi artrit: klinicheskie rekomendatsii dlya pediatrov [Juvenile Arthritis: Clinical Guidelines for Pediatricians]. Мoscow, Pediatr, 2013. 120 p.Baranov А.А., Alexeeva E.I. Yuvenil'nyi artrit: klinicheskie rekomendatsii dlya pediatrov [Juvenile Arthritis: Clinical Guidelines for Pediatricians]. Мoscow, Pediatr, 2013. 120 p.Baranov A.A., Alexeeva E.I., Bzarova T.M., Valieva S.I., Denisova R.V., Isaeva K.B., Karagulyan N.A., Litvitskiy P.F., Mitenko E.V., Sleptsova T.V., Fetisova A.N., Chistyakova E.G., Taibulatov N.I., Morev S.Yu. Protokol vedeniya patsientov s yuvenil'nym artritom [Management Protocol for Patients with Juvenile Arthritis]. Voprosi sovremennoi pediatrii = Current Pediatrics. 2013;12:37–56.Baranov A.A., Alexeeva E.I., Bzarova T.M., Valieva S.I., Denisova R.V., Isaeva K.B., Karagulyan N.A., Litvitskiy P.F., Mitenko E.V., Sleptsova T.V., Fetisova A.N., Chistyakova E.G., Taibulatov N.I., Morev S.Yu. Protokol vedeniya patsientov s yuvenil'nym artritom [Management Protocol for Patients with Juvenile Arthritis]. Voprosi sovremennoi pediatrii = Current Pediatrics. 2013; 12: 37–56.Alexeeva E. I., Valieva S. I., Bzarova T. M., Semikina E. L., Isaeva K. B., Lisitsyn A. O., Denisova R. V., Chistyakova E. G. Efficacy and safety of repeat courses of rituximab treatment in patients with severe refractory juvenile idiopathic arthritis. Clin. Rheumatol. 2011;30:1163–1172.Alexeeva E.I., Valieva S.I., Bzarova T.M., Semikina E.L., Isaeva K.B., Lisitsyn A.O., Denisova R.V., Chistyakova E.G. Efficacy and safety of repeat courses of rituximab treatment in patients with severe refractory juvenile idiopathic arthritis. Clin. Rheumatol. 2011; 30: 1163–1172.Amor B., Dougados M., Listrat V., Menkes C. J., Roux H., Benhamou C., Blotman F., Pattin S., Paolaggi J. B., Duquesnoy B. Are classification criteria for spondylarthropathy useful as diagnostic criteria? Rev. Rhum. Engl. Ed. 1995;62:10–15.Amor B., Dougados M., Listrat V., Menkes C.J., Roux H., Benhamou C., Blotman F., Pattin S., Paolaggi J.B., Duquesnoy B. Are classification criteria for spondylarthropathy useful as diagnostic criteria? Rev. Rhum. Engl. Ed. 1995; 62: 10–15.Beukelman T., Patkar N. M., Saag K. G., Tolleson-Rinehart S., Cron R.Q., DeWitt E. M., Ilowite N. T., Kimura Y., Laxer R. M., Lovell D. J., Martini A., Rabinovich C. E., Ruperto N. 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features. Arthritis Care Res (Hoboken). 2011;63:465–482.Beukelman T., Patkar N.M., Saag K.G., Tolleson-Rinehart S., Cron R.Q, DeWitt E.M., Ilowite N.T., Kimura Y., Laxer R.M., Lovell D.J., Martini A., Rabinovich C.E., Ruperto N. 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features. Arthritis Care Res (Hoboken). 2011; 63: 465–482.Cassidy J. T. Textbook of pediatric rheumatology. 6th edn. Philadelphia: Saunders. 2011. 800 p.Cassidy J.T. Textbook of pediatric rheumatology. 6th edn. Philadelphia: Saunders. 2011. 800 p.Dougados M., van der Linden S., Juhlin R., Huitfeldt B., Amor B., Calin A., Cats A., Dijkmans B., Olivieri I., Pasero G. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum. 1991;34:1218–1227.Dougados M., van der Linden S., Juhlin R., Huitfeldt B., Amor B., Calin A., Cats A., Dijkmans B., Olivieri I., Pasero G. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum. 1991; 34: 1218–1227.Hafner R. Juvenile spondarthritis. Retrospective study of 71 patients. Monatsschr Kinderheilkd. 1987;135:41–46.Häfner R. Juvenile spondarthritis. Retrospective study of 71 patients. Monatsschr Kinderheilkd. 1987; 135: 41–46.Horneff G., Burgos-Vargas R. Juvenile idiopathic arthritis. Subgroup characteristics and comparisons between rheumatoid arthritis-like subgroups and ankylosing spondylitis-like subgroups. Clin. Exp. Rheumatol. 2009;27:131–138.Horneff G., Burgos-Vargas R. Juvenile idiopathic arthritis. Subgroup characteristics and comparisons between rheumatoid arthritis-like subgroups and ankylosing spondylitis-like subgroups. Clin. Exp. Rheumatol. 2009; 27: 131–138.Hussein A., Abdul-Khaliq H., von der Hardt H. Atypical spondylo-arthritis in children: proposed diagnostic criteria. Eur. J. Pediatr. 1989; 148: 513–517.Hussein A., Abdul-Khaliq H., von der Hardt H. Atypical spondyloarthritis in children: proposed diagnostic criteria. Eur. J. Pediatr. 1989; 148: 513–517.Martini A. Systemic juvenile idiopathic arthritis. Autoimmun. Rev. 2012; 12: 56–59.Martini A. Systemic juvenile idiopathic arthritis. Autoimmun. Rev. 2012; 12: 56–59.Marzan K. A. B., Shaham B. Early juvenile idiopathic arthritis. Rheum. Dis. Clin. North Am. 2012; 38: 355–372.Marzan K.A.B., Shaham B. Early juvenile idiopathic arthritis. Rheum. Dis. Clin. North Am. 2012; 38: 355–372.Otten M. H., Anink J., Spronk S., van Suijlekom-Smit L. W. Efficacy of biological agents in juvenile idiopathic arthritis: a systematic review using indirect comparisons. Ann. Rheum. Dis. 2013; 72: 1806–1812. DOI: 10.1136/annrheumdis-2012-201991.Otten M.H., Anink J., Spronk S., van Suijlekom-Smit L.W. Efficacy of biological agents in juvenile idiopathic arthritis: a systematic review using indirect comparisons. Ann. Rheum. Dis. 2013; 72: 1806–1812. DOI: 10.1136/annrheumdis-2012-201991.Petty R. E., Southwood T. R., Manners P., Baum J., Glass D. N., Goldenberg J., He X., Maldonado-Cocco J., Orozco-Alcala J., Prieur A. M., Suarez-Almazor M. E., Woo P. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J. Rheumatol. 2004; 31: 390–392.Petty R.E., Southwood T.R., Manners P., Baum J., Glass D.N., Goldenberg J., He X., Maldonado-Cocco J., Orozco-Alcala J., Prieur A.M., Suarez-Almazor M.E., Woo P.; International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J. Rheumatol. 2004; 31: 390–392.Sandborg C., Mellins E. D. A new era in the treatment of systemic juvenile idiopathic arthritis. N. Engl. J. Med. 2012; 367: 2439–2440.Sandborg C., Mellins E.D. A new era in the treatment of systemic juvenile idiopathic arthritis. N. Engl. J. Med. 2012; 367: 2439–2440.Wallace C. A., Giannini E. H., Huang B., Itert L., Ruperto N. American College of Rheumatology provisional criteria for defining clinical inactive disease in select categories of juvenile idiopathic arthritis. Arthritis Care Res. (Hoboken). 2011; 63: 929–936.Wallace C.A., Giannini E.H., Huang B., Itert L., Ruperto N. American College of Rheumatology provisional criteria for defining clinical inactive disease in select categories of juvenile idiopathic arthritis. Arthritis Care Res. (Hoboken). 2011; 63: 929–936.Wallace C. A., Giannini E. H., Spalding S. J., Hashkes P. J., O'Neil K. M., Zeft A. S., Szer I. S., Ringold S., Brunner H. I., Schanberg L. E., Sundel R. P., Milojevic D., Punaro M. G., Chira P., Gottlieb B. S., Higgins G. C., Ilowite N. T., Kimura Y., Hamilton S., Johnson A., Huang B., Lovell D. J. Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis. Arthritis Rheum. 2012; 64: 2012–2021.Wallace C.A., Giannini E.H., Spalding S.J., Hashkes P.J., O'Neil K.M., Zeft A.S., Szer I.S., Ringold S., Brunner H.I., Schanberg L.E., Sundel R.P., Milojevic D., Punaro M.G., Chira P., Gottlieb B.S., Higgins G.C., Ilowite N.T., Kimura Y., Hamilton S., Johnson A., Huang B., Lovell D.J.; Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis. Arthritis Rheum. 2012; 64: 2012–2021.

The authors declare that there are no conflicts of interest present.